Robert L. Ferrara - 11 Sep 2024 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Director
Signature
/s/ Robert M. Infarinato, Attorney-in-fact
Issuer symbol
PHIO
Transactions as of
11 Sep 2024
Net transactions value
$0
Form type
4
Filing time
12 Sep 2024, 16:11:23 UTC
Previous filing
15 Jun 2023
Next filing
21 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Award $0 +10,000 $0.000000 10,000 11 Sep 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in one year on the first anniversary.
F2 Includes shares of common stock underlying unvested restricted stock units.